The ASX has slipped so far on Thursday with energy stocks down. Amcor fell on restructure news, while Mesoblast landed ...

Mesoblast, a regenerative medicines developer with a market capitalization of $3.1 billion, is set to be included in the ...

Mesoblast shares fell by more than 5% in morning trade after the dual-listed biotech company was added to the ASX 200 index.

Economists raise odds of recession as sentiment falls, tariff-related uncertainty rises ( Bloomberg) Trump's tariffs raise ...

Australia’s S&P/ASX 200 looks set to pare losses compiled across back-to-back declines after U.S. stocks rallied amid signs of flexibility on tariffs from President Trump.

A better session is expected for Aussie investors today. The post 5 things to watch on the ASX 200 on Thursday appeared first ...

This fund manager is skilled at picking out S&P/ASX 200 Index (ASX: XJO) share opportunities. These two stocks could be top ...

Up 112% in a year, investors are sending the S&P/ASX 200 Index (ASX: XJO) gold stock flying higher again today. Here’s what ...

In a special report ahead of International Women's Day, Kristie Batten takes stock of the mining industry's progress on ...

Sky News Business Reporter Edward Boyd claims US President Donald Trump’s latest announcement on trade tariffs had a “big ...

With US tariffs now in effect on several countries and retaliatory tariffs also being announced, equities remain under ...

Shares lower, Trump talks tariffs; China dramatically boosts deficit; Virgin’s new CEO; MinRes debt downgraded; WiseTech ...